Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma

Abroad (travel likely)RecruitingPHASE1

Conditions

Central Nervous System Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

City of Hope Medical Center, Duarte, California, United States
Contact: Study coordinator (Tanya Siddiqi) · tsiddiqi@coh.org · 626-803-3458
Contact: Principal Investigator (Tanya Siddiqi)

Study leads

Tanya Siddiqi
Principal Investigator
City of Hope Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Q702 for the Treatment of Patients With Hematologic Malignancies

Hematopoietic and Lymphatic System Neoplasm · Histiocytic Sarcoma · Malignant Histiocytosis

Abroad (travel likely)RecruitingPHASE1

Scottsdale, United States · Rochester, United States

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL) · Diffuse Large B Cell Lymphoma (DLBCL)

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · San Francisco, United States

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Chronic Lymphocytic Leukemia (CLL) · Small Lymphocytic Lymphoma (SLL) · Waldenstrom Macroglobulinemia (WM)

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Orange, United States

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Lymphoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Tampa, United States